Omega-3 supplementation and heart failure: A meta-analysis of 12 trials including 81,364 participants

Contemp Clin Trials. 2021 Aug:107:106458. doi: 10.1016/j.cct.2021.106458. Epub 2021 May 28.

Abstract

Heart failure (HF) remains a leading cause of hospitalization and mortality. Marine omega-3 fatty acid supplements (omega-3 s) have shown efficacy in decreasing sudden cardiac death and improving the left ventricle ejection fraction percent (LVEF%). In this review, we evaluated the effect of marine omega-3 fatty acid supplements (omega-3 s) on HF hospitalization, recurrent HF hospitalization, and cardiovascular mortality in patients with heart failure. We found that omega-3 supplementation did not reduce first HF hospitalization or cardiovascular mortality but did significantly reduce recurrent HF hospitalizations, as compared with placebo.

Keywords: Heart failure; Hospitalization; Omega-3 fatty acids.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dietary Supplements
  • Heart Failure* / drug therapy
  • Hospitalization
  • Humans
  • Stroke Volume
  • Ventricular Function, Left